DARVIAS® Injection 135 mg

DARVIAS® Injection 135 mg

DARVIAS® Injection 135 mgDARVIAS® Injection 135 mg


Trade name DARVIAS® Injection 135mg
Drug Classification Antineoplastic agent / Organic arsenic product
Generic name Darinaparsin
Indications Relapsed or refractory peripheral T-cell lymphoma (PTCL)
Regulatory Category Powerful drug・Prescription-only drug (Caution - Use it under a prescription of a physician, etc.)

The distributor in Japan is Nippon Kayaku Co. Ltd.
For more information, please link to Nippon Kayaku website below; (only available in Japanese)